CHP Beauregard
About CHP Beauregard
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CHP Beauregard
During the past decade, CHP Beauregard conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer
2001-02-01
2013-03-01
Completed
4,813
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer
2009-11-01
2013-06-01
Completed
339
Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
2011-01-01
2023-04-01
Unknown status
1,503
The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer
2012-07-01
2022-12-01
Active, not recruiting
206
Effectiveness of a Website and Telemonitoring in Patients With Heart Failure.
2013-09-01
2015-12-01
Completed
450
Impact on Management of the HEART Risk Score in Chest Pain Patients
2013-07-01
2015-03-01
Completed
3,666
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CHP Beauregard" #1 sponsor was "LivaNova" with 3 trials, followed by "Biosensors Europe SA" with 1 trials
sponsored, "European Cardiovascular Research Center" with 1 trials sponsored, "French Cardiology Society" with 1 trials sponsored and "Hexacath, France"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at CHP Beauregard
According to Clinical.Site data, the most researched conditions in "CHP Beauregard" are
"Acute Coronary Syndrome" (1 trials), "Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients." (1 trials), "Atrial Fibrillation, Persistent" (1 trials), "Biventricular Tachycardias" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "CHP Beauregard" in a lesser frequency.
Clinical Trials Intervention Types at CHP Beauregard
Most popular intervention types in "CHP Beauregard" are "Device" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ablation by radiofrequency of low-voltage areas" (1 trials), "Angioplasty (PROMUS Element™, and Xience™ Prime stent)" (1 trials), "Cardiac Resynchronization Therapy -Defibrillator (range PARADYM, LivaNova, Clamart, France)" (1 trials), "Cobalt-Chromium Bare Metal Stents" (1 trials) and "Isolation of pulmonary veins" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CHP Beauregard
The vast majority of trials in "CHP Beauregard" are
8 trials for "All" genders.
Clinical Trials Status at CHP Beauregard
Currently, there are NaN active trials in "CHP Beauregard".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in CHP Beauregard,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHP Beauregard, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 1 trials that are defined as “Not Applicable".